Artelo Biosciences, Inc. (ARTL) Tops Q3 EPS by 44c
Tweet
Share
E-mailGet Alerts ARTL Hot Sheet
Join SI Premium – FREE
Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.35), $0.44 better than the analyst estimate of ($0.79).
For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
